← Leaderboards
Sarah Elizabeth Vordenberg
University Of Michigan At Ann Arbor
$1,024,808
Attributed
$2,049,616
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $715.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,049,616 · 1
By mechanism
R01$2,049,616 · 1
Top collaborators
- Donovan T Maust3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Daniel Robert Goldstein$17,752,903
- Margaret Takako Hicken$10,480,990
- James Anthony Ashton-Miller$9,179,244
- Laurel L. Northouse$5,558,442
- Vanessa K., Md, Mph Dalton$4,104,008
Others in their field
Other Rising Stars on “Complex”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$58,129,860
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Maximilian Haeussler · University Of California Santa Cruz$13,899,136
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Jason Dickens · Duke University$12,259,409
Research focus
ComplexData SetCommunitiesAmericanAgonistAccountingAlzheimer&AposCombination MedicationAntipsychotic AgentsAttitudeBehavioral SymptomsBehavior ControlBeliefBeneficiaryBenzodiazepine ReceptorBenzodiazepinesAgitationCohortCaringCentral Nervous SystemCessation Of LifeCharacteristicsClinical Decision-MakingDecision Making
Grant awards (3)
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia$715,096
R01 · FY2025 · AG
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia$664,410
R01 · FY2024 · AG
Prescribing without a guide: A national study of psychotropic and opioid polypharmacy among persons living with dementia$670,110
R01 · FY2023 · AG